SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Akumin Inc. – ‘8-K’ for 9/1/22

On:  Friday, 9/2/22, at 1:35pm ET   ·   For:  9/1/22   ·   Accession #:  1193125-22-237731   ·   File #:  1-39479

Previous ‘8-K’:  ‘8-K’ on 8/18/22 for 8/12/22   ·   Next:  ‘8-K’ on 10/3/22 for 9/30/22   ·   Latest:  ‘8-K’ on 2/7/24 for 2/6/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/02/22  Akumin Inc.                       8-K:5,8     9/01/22   10:138K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     24K 
 5: R1          Document and Entity Information                     HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d402109d8k_htm                      XML     13K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- aku-20220901_lab                      XML     55K 
 4: EX-101.PRE  XBRL Presentations -- aku-20220901_pre               XML     35K 
 2: EX-101.SCH  XBRL Schema -- aku-20220901                          XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
10: ZIP         XBRL Zipped Folder -- 0001193125-22-237731-xbrl      Zip     11K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i 00-0000000  i 0001776197  i false 0001776197 2022-09-01 2022-09-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

 i September 1, 2022

 

 

 i Akumin Inc.

(Exact name of Registrant as specified in its charter)

 

 

 

 i Ontario    i 001-39479   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 i 8300 W. Sunrise Boulevard

 i Plantation,  i Florida

   i 33322
(Address of principal executive offices)   (Zip Code)

( i 844)  i 730-0050

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered or to be registered pursuant to Section 12(b) of the Act.

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

 i Common Shares, no par value    i AKU    i The Nasdaq Stock Market LLC
Common Shares, no par value   AKU   Toronto Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  i 

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 1, 2022, William Larkin, the Company’s former Chief Financial Officer, entered into a Confidential Separation Agreement and General Release (“Separation Agreement”) with the Company and Alliance Healthcare Services, Inc., which will become effective on September 8, 2022 (the “Effective Date”) unless Mr. Larkin revokes the Separation Agreement. Pursuant to the terms of the Separation Agreement, the Company agreed to pay Mr. Larkin severance pay equal to $600,000.00, which is 18 months of his then-current annual base salary of $400,000.00, and an enhanced bonus of $450,000.00, which is one-and-one-half times of Mr. Larkin’s target bonus for his service to the Company in 2021, payable in bi-weekly instalments over an 18 month period. Under the Separation Agreement, the Company agreed to pay Mr. Larkin $38,000.00, which is the cash equivalent for the cancellation of Mr. Larkin’s 50,000 restricted share units, within five business days of the Effective Date. Mr. Larkin is also entitled to up to $35,000.00 in outplacement services provided by an outplacement services company of the Company’s choosing and a bi-weekly payment in an amount equal to Company’s group health (medical, dental and vision, where applicable) coverage expense for Mr. Larkin and his dependents (where previously enrolled).

Item 8.01. Other Events.

On August 31, 2022, the Company received a formal notification via letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company had regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), which requires that the Company’s common stock maintain a minimum bid price of at least $1.00 per share, and that the matter is now closed.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Akumin Inc.
Date: September 2, 2022     By:  

/s/ Riadh Zine

     

Riadh Zine

Chief Executive Officer


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
9/8/22
Filed on:9/2/22
For Period end:9/1/22
8/31/224
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/10/22  Akumin Inc.                       S-8 POS    11/10/22    3:72K                                    Donnelley … Solutions/FA
11/10/22  Akumin Inc.                       POS AM                 3:114K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-22-237731   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 9:16:49.1am ET